Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$202821.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$202821.0, up 31.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$386521.0 (down 65.26% YoY), and the FY2025 annual result was -$477642.0, down 210.62% from the prior year.
• Other Working Capital Changes came in at -$202821.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $184475.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.1 million in Q4 2023 to a low of -$1.4 million in Q2 2022.
• The 5-year median for Other Working Capital Changes is -$210859.0 (2024), against an average of $169996.5.
• Peak annual rise in Other Working Capital Changes reached 240.05% in 2025, while the deepest fall reached 1172.91% in 2025.
• Cumberland Pharmaceuticals' Other Working Capital Changes stood at $2.5 million in 2022, then surged by 63.87% to $4.1 million in 2023, then tumbled by 94.84% to $209073.0 in 2024, then fell by 11.77% to $184475.0 in 2025, then sank by 209.94% to -$202821.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$202821.0 (Q1 2026), $184475.0 (Q4 2025), and -$663488.0 (Q3 2025), per Business Quant data.